Literature DB >> 28217473

CD34 negative superficial acral fibromyxoma: A rare case report.

Reza M Robati1, Sahar Dadkhahfar1, Azadeh Rakhshan2.   

Abstract

Superficial acral fibromyxoma (SAF) is a slow growing soft tissue tumor that mainly appears in the acral areas. Here, we report a case of a SAF with distinctive immunophenotype charachteristics. An 18-year-old female was referred to our clinic with the complaint of painless subungual nodule of great toe for a few months. The diagnosis of SAF was made according to histopathology and immunohistochemical (IHC) study, however, the IHC assessment showed positive staining with vimentin, focal reaction with smooth muscle actin, negative reaction with CD34, and positive staining pattern with CD99. These IHC findings are unusual for SAF. This reported case of SAF supports the fact that, although CD34 expression is characteristic for SAF, it is not always present.

Entities:  

Keywords:  Benign soft tissue tumor; CD34; immunohistochemical (IHC) study; superficial acral fibromyxoma

Year:  2017        PMID: 28217473      PMCID: PMC5297271          DOI: 10.4103/2229-5178.198776

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN: 2229-5178


  16 in total

1.  Onychomatricoma: an often misdiagnosed tumor of the nails.

Authors:  Camilo Andrés Morales-Cardona; Álvaro Andrés Luque-Acevedo; Luis Fernando Bermúdez-Bula
Journal:  Cutis       Date:  2015-08

2.  Diagnostic Pitfalls of Differentiating Cellular Digital Fibroma from Superficial Acral Fibromyxoma.

Authors:  Jin Yong Lee; So Eun Park; Soo Jung Shin; Chul Woo Kim; Sang Seok Kim
Journal:  Ann Dermatol       Date:  2015-07-29       Impact factor: 1.444

3.  Superficial acral fibromyxoma: clinical and pathological features.

Authors:  Josette André; Anne Theunis; Bertrand Richert; Nicolas de Saint-Aubain
Journal:  Am J Dermatopathol       Date:  2004-12       Impact factor: 1.533

4.  Superficial acral fibromyxoma: clinicopathological study of 14 cases with emphasis on a cellular variant.

Authors:  Bostjan Luzar; Eduardo Calonje
Journal:  Histopathology       Date:  2009-02       Impact factor: 5.087

5.  Subungual Acral Fibromyxoma Involving the Bone: A Mimicker of Malignancy.

Authors:  Carmen Carranza; Ana María Molina-Ruiz; Teresa Pérez de la Fuente; Heinz Kutzner; Luis Requena; Carlos Santonja
Journal:  Am J Dermatopathol       Date:  2015-07       Impact factor: 1.533

Review 6.  Clinical and histopathological diagnosis of glomus tumor: an institutional experience of 138 cases.

Authors:  Marco Mravic; Gregory LaChaud; Alan Nguyen; Michelle A Scott; Sarah M Dry; Aaron W James
Journal:  Int J Surg Pathol       Date:  2015-01-22       Impact factor: 1.271

7.  Digital fibromyxoma (superficial acral fibromyxoma): a detailed characterization of 124 cases.

Authors:  Travis J Hollmann; Judith V M G Bovée; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2012-06       Impact factor: 6.394

8.  Superficial acral fibromyxoma: a clinicopathological study of new 41 cases from the U.K.: should myxoma (NOS) and fibroma (NOS) continue as part of 21st-century reporting?

Authors:  R J Prescott; E A Husain; A Abdellaoui; R M W Al-Mahmoud; M Khan; W D Salman; Z Twaij; B G Zelger; B Zelger; W I Al-Daraji
Journal:  Br J Dermatol       Date:  2008-09-01       Impact factor: 9.302

9.  Acral myxoinflammatory fibroblastic sarcoma: case series and immunohistochemical analysis.

Authors:  Carrie L Kovarik; Terry Barrett; Aaron Auerbach; David S Cassarino
Journal:  J Cutan Pathol       Date:  2008-02       Impact factor: 1.587

10.  Superficial acral fibromyxoma: report of two cases.

Authors:  D V Kazakov; T Mentzel; G Burg; W Kempf
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

View more
  1 in total

1.  Aggressive superficial acral fibromyxoma of the great toe: A case report and mini-review of the literature.

Authors:  Kazuhiko Hashimoto; Shunji Nishimura; Naohiro Oka; Hiroki Tanaka; Ryosuke Kakinoki; Masao Akagi
Journal:  Mol Clin Oncol       Date:  2018-07-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.